| Hormone Therapy studied in …STUDIED_INderived73 of 73show fewer |
|---|
| → studied in | NCT06637150Phase 3 · recruiting Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04923542Phase 1/Phase 2 · recruiting SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844759NA · not yet recruiting SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm,Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573648Phase 2 · active not recruiting Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407920Phase 2 · recruiting Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial · 73 trials list this drug (41 active) | — | — | Early Stage HER2-Positive Breast Carcinoma,Early Stage Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07826052Phase 2 · not yet recruiting Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05306041Phase 2 · recruiting Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer · 73 trials list this drug (41 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05448547Phase 3 · recruiting Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer · 73 trials list this drug (41 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03820830Phase 3 · active not recruiting Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07613151recruiting Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study · 73 trials list this drug (41 active) | — | — | Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134260Phase 3 · active not recruiting Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial · 73 trials list this drug (41 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914440Phase 2 · recruiting Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762924Phase 2 · recruiting Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery · 73 trials list this drug (41 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745257Phase 2 · not yet recruiting Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369285Phase 2 · recruiting A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer · 73 trials list this drug (41 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07683754Phase 3 · not yet recruiting T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915508Phase 2 · active not recruiting Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy · 73 trials list this drug (41 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708194Phase 1/Phase 2 · recruiting Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure · 73 trials list this drug (41 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04619069Phase 1/Phase 2 · active not recruiting Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer · 73 trials list this drug (41 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02764541Phase 2 · active not recruiting Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07610720Phase 2 · recruiting Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578116Phase 3 · not yet recruiting Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis · 73 trials list this drug (41 active) | — | — | Oligometastatic Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852887Phase 3 · recruiting De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05399329completed Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07112053Phase 2 · recruiting A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer · 73 trials list this drug (41 active) | — | — | HER2-Negative Breast Carcinoma,Hormone Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024462Phase 3 · completed A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389174early Phase 1 · not yet recruiting Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057133Phase 1 · active not recruiting A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread · 73 trials list this drug (41 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07019363Phase 3 · recruiting CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04584853Phase 3 · active not recruiting PreOperative Endocrine Therapy for Individualised Care With Abemaciclib · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717166Phase 3 · recruiting A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. · 73 trials list this drug (41 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02352883NA · active not recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ · 73 trials list this drug (41 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03676257completed Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041842Phase 2 · active not recruiting Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03519178Phase 1/Phase 2 · terminated A Study of PF-06873600 in People With Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03721341Phase 3 · active not recruiting Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors · 73 trials list this drug (41 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101159Phase 2 · not yet recruiting Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03725059Phase 3 · active not recruiting Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005557Phase 3 · not yet recruiting Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06924229Phase 4 · completed Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04109066Phase 3 · completed Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01897441NA · terminated Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06044623Phase 3 · recruiting Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176534Phase 2 · recruiting Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548919recruiting Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493854Phase 3 · completed A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer · 73 trials list this drug (41 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02448420Phase 2 · completed Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06341894Phase 2 · recruiting Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer · 73 trials list this drug (41 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03321981Phase 2 · completed MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03809988Phase 2 · completed PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983107Phase 2 · recruiting Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03969121Phase 3 · completed Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer · 73 trials list this drug (41 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411380Phase 2 · unknown Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor. · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03184090Phase 2 · completed Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366130Phase 2 · completed Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03818100unknown Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03955939Phase 1 · completed A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301375Phase 2 · not yet recruiting Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial) · 73 trials list this drug (41 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00240071Phase 2 · completed Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca. · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04023292Phase 2 · unknown Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer · 73 trials list this drug (41 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02913859Phase 2 · unknown Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer · 73 trials list this drug (41 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03701659NA · unknown TUPKRP Combined With MAB Therapy for LUTS/PCa · 73 trials list this drug (41 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01973660Phase 2 · completed PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01142778Phase 2 · completed A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03390608completed Prognostic and Predictive Factors for Small Breast Tumors · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684216Phase 2/Phase 3 · terminated Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204734Phase 2 · unknown Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00647218NA · completed Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00138008Phase 3 · completed Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy · 73 trials list this drug (41 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00373191completed Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839994Phase 3 · unknown Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer · 73 trials list this drug (41 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00929591Phase 3 · completed SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer · 73 trials list this drug (41 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00764166Phase 3 · unknown A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel · 73 trials list this drug (41 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |